Acomplia is a revolutionary new slimming aid which has been developed by Sanofi-Aventis. Acomplia has only just become available to purchase or prescribe.Acomplia is a prescription medication so you must consult with doctor before you can purchase this medication.
Recent clinical trial results have reinforced earlier results which demonstrated that Acomplia (Rimonabant) helped overweight people lose pounds and keep the weight off after they had ceased the treatment. The study also suggested that Acomplia (Rimonabant) helps to reduce the dangerous visceral fat in the abdominal cavity which is linked to diabetes and heart disease.
The two year study concluded that patients lost an average of 19 pounds and 3 inches from their waist circumference after taking Acomplia (Rimonabant) as a slimming aid. There is also evidence to suggest that Acomplia (Rimonabant) might be effective in helping people who want to give up smoking although it has not been approved for this purpose.
Acomplia (rimonabant) works by blocking the CB1 receptors in the brain and fat tissue. Cannabinoids, chemicals produced by the body, latch on to the CB1 receptors, sending out a signal that prompts people to eat more. These receptors tend to be more active in overweight people. By blocking these receptors, it has been demonstrated that this will help normalise the endocannabinoid system, making hunger pangs more manageable.
Source-:www.theonlineclinic.co.uk
